Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare skeletal dysplasia characterized by congenital dislocation of large joints, foot deformities, cervical spine dysplasia, scoliosis, spatula-shaped distal phalanges and distinctive craniofacial abnormalities, including cleft palate.
Features include very common findings: Spatulate thumbs, Midface retrusion, Hip dislocation, and Knee dislocation; and common findings: Short stature, Elbow dislocation, Vertebral fusion, and Sideways curvature of the spine (scoliosis) and others. 49 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 7 | Joint hypermobility, Vertebral fusion, Cervical kyphosis |
FLNB encodes filamin B (2,602 aa). Connects cell membrane constituents to the actin cytoskeleton. May promote orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Highest expression in Nerve Tibial (192.4 TPM) and Uterus (108.4 TPM).
Larsen syndrome is associated with mutations in the FLNB gene on chromosome 3.
FLNB is classified as a druggable target (Transporter category) with score 0.0.
Formal diagnostic criteria for FLNB-related disorders have not been established. The FLNB-related disorders can be divided into two groups of conditions caused by loss of function or gain of function of filamin-B. Biallelic loss-of-function pathogenic variants in FLNB cause spondylocarpotarsal synostosis syndrome (FLNB-SCT). Monoallelic gain-of-function pathogenic variants in FLNB cause a spectrum of phenotypic severity ranging from apparently isolated clubfoot to Larsen syndrome (FLNB-LS), atelosteogenesis type 3 (FLNB-AO3), and atelosteogenesis type 1 (FLNB-AO1), which is perinatal lethal. For the purposes of this GeneReview, the previously described entities Piepkorn dysplasia and boomerang dysplasia are subsumed under the FLNB-AO1 spectrum.
No approved treatments are currently available for Larsen syndrome. The disease remains an area of unmet medical need.
No clinical practice guidelines for FLNB-related disorders have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with an FLNB-related disorder, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. FLNB-Related Disorders: Recommended Surveillance
No clinical trials have been registered for Larsen syndrome.
13 publications have been identified in PubMed for Larsen syndrome. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 46% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Larsen syndrome
Head and neck |
3 |
Cleft palate, Cleft upper lip, Flat face |
Heart and blood vessels | 3 | Ventricular septal defect, Atrial septal defect, Aortic aneurysm |
Ears | 2 | Hearing loss (hearing impairment), Conductive hearing impairment |
Growth and development | 2 | Short stature, Intrauterine growth retardation |
Brain and nerves | 2 | Intellectual disability, Depressed nasal bridge |
Eyes | 1 | Cloudy or opaque cornea (corneal opacity) |
Lungs and breathing | 1 | Bronchomalacia |
Skin | 1 | Short nail |
Age of onset: at birth.
The FLNB-related disorders can be divided into two groups of conditions caused by loss of function or gain of function of filamin-B. Biallelic loss-of-function pathogenic variants in FLNB cause spondylocarpotarsal synostosis syndrome (FLNB-SCT). Monoallelic gain-of-function pathogenic variants in FLNB cause a spectrum of phenotypic severity ranging from apparently isolated clubfoot to Larsen syndrome (FLNB-LS), atelosteogenesis type 3 (FLNB-AO3), and atelosteogenesis type 1 (FLNB-AO1), which is perinatal lethal. For the purposes of this GeneReview, the previously described entities Piepkorn dysplasia, boomerang dysplasia, and spondylohumerofemoral (giant cell) dysplasia are subsumed under the FLNB-AO1 spectrum.
Source: GeneReviews — "FLNB-Related Disorders"
FLNB-SCT. Homozygosity or compound heterozygosity for pathogenic frameshift or nonsense variants in FLNB causes FLNB-SCT . Pathogenic variants associated with FLNB-SCT are associated with loss of protein expression and hence constitute true null alleles . Consequently, no genotype-phenotype association has been described. FLNB-LS, FLNB-AO1, and FLNB-AO3. The FLNB pathogenic variants associated with LS, AO1, and AO3 are either missense variants or small in-frame deletions and are predicted to encode full-length filamin-B protein.
Source: GeneReviews — "FLNB-Related Disorders"
Germline FLNB pathogenic variants associated with syndromic FLNB-related disorders are fully penetrant but show variable expressivity, leading to the range of phenotypes described in this GeneReview. Although most individuals with idiopathic congenital clubfoot presented with the malformation in isolation, and some kindreds seemed to indicate reduced penetrance , in some individuals, subtle phenotypic signs – such as elbow and thumb hypermobility, as well as wide, flat thumbs – have been identified that suggest mild manifestations within the clinical spectrum of LS .
Source: GeneReviews — "FLNB-Related Disorders"
Suggestive Findings
Source: GeneReviews — "FLNB-Related Disorders"
FLNB-related spondylocarpotarsal synostosis syndrome. See . Table 2. Genes of Interest in the Differential Diagnosis of FLNB-Related Spondylocarpotarsal Synostosis Syndrome
Gene(s) | Disorder | MOI | Features of Disorder |
|---|---|---|---|
TBX6 | Spondylocostal dysostosis (See Spondylocostal Dysostosis, Autosomal Recessive.) | AR(AD)1 | Vertebral dysplasia |
Rib anomalies FGF9GDF5GDF6NOG | Multiple synostoses syndrome (OMIM PS186500) | AD | Vertebral dysplasia |
GDF6 | GDF6-related Klippel-Feil syndrome (OMIM 118100) | AD | Vertebral, carpal, tarsal fusions |
MYH3 | MYH3-related SCT w/contractures pterygia (OMIM 178110 618469) | ADAR | Vertebral, carpal, tarsal fusions |
RFLNA | RFLNA-related SCT2 | AR | Vertebral, carpal, tarsal fusions |
Genes of Interest in the Differential Diagnosis of FLNB-Related Larsen Syndrome Gene | Disorder | MOI | Features of Disorder Overlapping w/FLNB-LS |
B3GAT3 | B3GAT3-related multiple joint dislocations, short stature, craniofacial dysmorphisms, skeletal dysplasia, w/ or w/o heart defects (OMIM 245600) | AR | Joint dislocations |
B4GALT7 | B4GALT7-related Ehlers-Danlos syndrome, spondylodysplastic type 1 (OMIM 130070) | AR | Joint dislocations |
BPNT2(IMPAD1) | BPNT2-related chondrodysplasia w/congenital joint dislocations (OMIM 614078) | AR | Joint dislocations |
CANT1 | CANT1-related Desbuquois dysplasia (w/accessory ossification center in digit 2) (OMIM 251450) | AR | Joint dislocations |
CHST3 | CHST3-related chondrodysplasia w/congenital joint dislocations1 | AR | Joint dislocations |
Source: GeneReviews — "FLNB-Related Disorders"
Genetic testing for FLNB is available. Testing is considered confirmatory for diagnosis.
Table 4.
FLNB-Related Disorders: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Lateral cervical spine radiographs in flexion extension | • To evaluate for cervical dysplasia, which can be associated w/cervical cord myelopathy
Evaluate cervical spine for instability prior to general anesthesia.
Spine radiographs | To evaluate for vertebral abnormalities that predispose to scoliosis
Clinical ultrasound assessment of hips for dislocation | Development of dislocations postnatally has not been described.
Clinical exam for joint dislocation, clubfoot |
ENT | Eval for cleft palate |
| Respiratory exam | For evidence of laryngotracheobronchomalacia
| Audiologic eval | To assess for sensorineural /or conductive hearing loss
| Ophthalmologic exam | To evaluate for retinal anomalies in those w/FLNB-SCT
| Eval for enamel hypoplasia need for sealants |
| By genetics professionals1 | To obtain a pedigree info...
Source: GeneReviews — "FLNB-Related Disorders"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "FLNB-Related Disorders"
View trials for Larsen syndrome
Evaluation |
|---|
Frequency |
|---|
Vertebral anomalies | Orthopedic eval for development of progressive scoliosis | Annually from birth |
Feeding for those w/cleft palate | Feeding growth assessment | Per multidisciplinary craniofacial team |
Audiologic | Audiologic exam | Annually Enamel hypoplasia |
Source: GeneReviews — "FLNB-Related Disorders"
Phenotype severity distribution: 4 very common features, 5 common features.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
3 |
23% |
Disease patterns and progression | 2 | 15% |
New treatment approaches | 2 | 15% |
Arrigo A (2026). [PMID: 41674076](https://pubmed.ncbi.nlm.nih.gov/41674076/). *HGG Adv*. [Gene Therapy / Novel Therapeutics]
Vialle R (2026). [PMID: 40976314](https://pubmed.ncbi.nlm.nih.gov/40976314/). *Orthopaedics & traumatology, surgery & research : OTSR*. [Review / Meta-Analysis]
Yokoyama-Rebollar E (2026). [PMID: 42170786](https://pubmed.ncbi.nlm.nih.gov/42170786/). *Am J Med Genet A*. [Review / Meta-Analysis]
Sabnis A (2026). [PMID: 42199394](https://pubmed.ncbi.nlm.nih.gov/42199394/). *J Clin Orthop Trauma*. [Case Report / Case Series]
Yoshiyama A (2025). [PMID: 40356807](https://pubmed.ncbi.nlm.nih.gov/40356807/). *Surgical case reports*. [Case Report / Case Series]
Juul TM (2025). [PMID: 41062856](https://pubmed.ncbi.nlm.nih.gov/41062856/). *Calcified tissue international*. [Case Report / Case Series]
Arrigo A (2025). [PMID: 41279393](https://pubmed.ncbi.nlm.nih.gov/41279393/). *bioRxiv*. [Gene Therapy / Novel Therapeutics]
Furuya M (2024). [PMID: 38868788](https://pubmed.ncbi.nlm.nih.gov/38868788/). *Spine surgery and related research*. [Case Report / Case Series]
Wilebski BJ (2024). [PMID: 38741359](https://pubmed.ncbi.nlm.nih.gov/38741359/). *The American journal of case reports*. [Case Report / Case Series]
Mallik S (2024). [PMID: 39563137](https://pubmed.ncbi.nlm.nih.gov/39563137/). *J Assoc Physicians India*. [Case Report / Case Series]
AI-curated news mentioning Larsen syndrome
Updated May 22, 2026
A recent study expands the understanding of GZF1-related phenotype, identifying it as a distinct ocular and skeletal disorder separate from Larsen syndrome. This research enhances the genetic and clinical knowledge surrounding these conditions.